Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Abstract Text:

M E Keck,M E Keck,M E Keck,

Affective disorders tend to be chronic and life-threatening diseases: suicide is estimated to be the cause of death in 10-15% of individuals with major depressive disorders. Major depression is one of the most prevalent and costly brain diseases with up to 20% of the worldwide population suffering from moderate to severe forms of the disease. Only 50% of individuals with depression show full remission in response to currently available antidepressant drug therapies which are based on serendipitous discoveries made in the 1950s. Previously underestimated, other severe depression-associated deleterious health-related effects have increasingly been recognized. Epidemiological studies have provided substantial evidence that patients with depression have a 2-4-fold increased risk both of developing cardiovascular disease and of mortality after experiencing a myocardial infarction. The majority of patients suffering from affective disorders have measurable shifts in their stress hormone regulation as reflected by elevated secretion of central and peripheral stress hormones or by altered hormonal responses to neuroendocrine challenge tests. In recent years, these alterations have increasingly been translated into testable hypotheses addressing the pathogenesis of illness. Refined molecular technologies and the creation of genetically engineered mice have allowed to specifically target individual genes involved in regulation of corticotropin releasing factor (CRF) and vasopressin (AVP) system elements. The cumulative evidence makes a strong case implicating dysfunction of these systems in the etiology and pathogenesis of depression and pathological anxiety. Translation of these advances into novel therapeutic strategies has already been started.

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Publishing Authors By Initials

ME Keck,ME Keck,ME Keck,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Amino acids

VOLUME: 31

Page Numbers: 241-50

Journal Abbreviation: Amino Acids

ISSN: 0939-4451

DAY: 29

MONTH: 05

YEAR: 2006

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9200312

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.

AFFILIATION: Division of Psychiatry Research, University Hospital of Psychiatry Zurich, Zurich, Switzerland.

Country: Austria

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Amino Acids

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety Related Publications

• A catalytic asymmetric vinylogous Mukaiyama aldol reaction.
• A central role for SSB in Escherichia coli RecQ DNA helicase function.
• A hand-off mechanism for primosome assembly in replication restart.
• An ultramicro technique for the determination of deoxypentose nucleic acid.
• Atypical antipsychotics in the treatment of bipolar disorder.
• Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
• Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.
• Emotional eating and emotional eating alternatives in subjects undergoing bariatric surgery.
• GRIN-V: progress in gradient-index imaging.
• Holographic procedures as an aid in diagnosis. Possibilities and limitations of application.
• Hypertrophic obstructive cardiomyopathy in neonatal beta-cell adenoma of the pancreas.
• Influence of nasal sponges on patients' complaints after nasal and sinus surgery.
• Left ventricular contractile state after surgical correction of tetralogy of Fallot: risk factors for late left ventricular dysfunction.
• Nasal conditioning after endonasal surgery in chronic rhinosinusitis with nasal polyps.
• Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
• Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
• Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder.
• Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
• Structure and function of the regulatory C-terminal HRDC domain from Deinococcus radiodurans RecQ.
• What procedural skills do deployed US navy family physicians need?
• [Effects of the contamination by polychlorobiphenyls (PCBs) on the growth of the Ehrlich tumor in mice (author's transl)]
• [Extended partial Kausch-Whipple duodenopancreatectomy by resection of tumor infiltrated vascular segments]
• [Osteoma of the frontal sinus leading to acute sinusitis with the complication of subdural empyema.]
• [Pancreatic incidentalomas. Correct assessment and therapy]
• [Physiology of ovarian function]
• [Premenstrual syndrome]
• [Progress in the field of liver transplantation in the last 10 years]
• [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)]
• [The corpus luteum]
• [Trypsin resistance of natural and heat-treated cells; studies with leukocytes and ascites tumor cells of mice.]